Since that CA9 knockdown halts MDA-MB-231 xenografts [22], the available data agree on the crucial role of the beta-catenin-dependent CA9 and SNAI2 mRNA stability and expression in the biology of basal-like/triple-negative breast cancer. Here, CA9 is linked to triple-negative breast carcinoma.